.Invite to this week's Chutes & Ladders, our summary of considerable management hirings, shooting...
.Complying with a poor showing for Lykos Therapeutics' MDMA applicant for post-traumatic stress diso...
.AN2 Therapies is actually reassessing its business in reaction to lackluster midphase data, pledgin...
.Merck & Co. is actually spending $700 million in advance to challenge Amgen in a blood cancer ma...
.Along With Gilead Sciences about to an FDA choice for its liver disease medication seladelpar, the ...
.Chief executive officer David Ricks can see the providers putting together tents at basecamp respon...
.Mattress Liquidators has actually switched Entero Therapies white colored as a sheet. The collector...
.Exelixis is actually losing hope on its own cells element (TF)- targeting antibody-drug conjugate a...
.Three full weeks after Roche's Genentech device bowed out an SHP2 prevention pact, Relay Therapeuti...
.Stoke Therapies' Dravet disorder medication has been actually freed from a predisposed hold, removi...